Inventor
DELABARRE BYRON
US18 patents
⚠️ This page may combine multiple inventors who share the name “DELABARRE BYRON”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
AGIOS PHARMACEUTICALS INC
5 patentsUS9512107B2Dec 6, 2016
Therapeutically active compositions and their methods of use
AGIOS PHARMACEUTICALS INC25 citations94
US9732062B2Aug 15, 2017
Therapeutically active compounds and their methods of use
AGIOS PHARMACEUTICALS INC18 citations92
US9656999B2May 23, 2017
Therapeutically active compounds and their methods of use
AGIOS PHARMACEUTICALS INC16 citations92
US10294215B2May 21, 2019
Therapeutically active compounds and their methods of use
AGIOS PHARMACEUTICALS INC6 citations84
US11505538B1Nov 22, 2022
Therapeutically active compounds and their methods of use
AGIOS PHARMACEUTICALS INC1 citations73
SILVER CREEK PHARMACEUTICALS INC
5 patentsUS10407512B2Sep 10, 2019
Bi-specific fusion proteins
SILVER CREEK PHARMACEUTICALS INC9 citations91
US10988547B2Apr 27, 2021
Bi-specific fusion proteins
SILVER CREEK PHARMACEUTICALS INC6 citations83
US10858450B2Dec 8, 2020
Bi-specific fusion proteins
SILVER CREEK PHARMACEUTICALS INC6 citations82
US11814443B2Nov 14, 2023
Bi-specific fusion proteins
SILVER CREEK PHARMACEUTICALS INC1 citations72
US11673970B2Jun 13, 2023
Bi-specific fusion proteins
SILVER CREEK PHARMACEUTICALS INC1 citations71
OBSIDIAN THERAPEUTICS INC
4 patentsUS11666642B2Jun 6, 2023
PDE5 compositions and methods for immunotherapy
OBSIDIAN THERAPEUTICS INC9 citations81
US11241485B2Feb 8, 2022
PDE5 compositions and methods for immunotherapy
OBSIDIAN THERAPEUTICS INC11 citations81
US11629340B2Apr 18, 2023
DHFR tunable protein regulation
OBSIDIAN THERAPEUTICS INC2 citations68
US12104178B2Oct 1, 2024
DHFR tunable protein regulation
OBSIDIAN THERAPEUTICS INC1 citations58